HealthyWay Inc. Expands into AI-Powered Specialized Disease Management with New Liver Disease Platform
Reuters
Jun 16
HealthyWay Inc. Expands into AI-Powered Specialized Disease Management with New Liver Disease Platform
HealthyWay Inc., a company incorporated in the Cayman Islands, has announced a significant expansion in its business operations with the launch of a pioneering project in the field of AI-powered specialized disease management. The project, titled "Construction and Validation of Intelligent Service Platform for Liver Diseases," was developed in collaboration with Professor Jia Ji-Dong of Beijing Friendship Hospital and has been selected under the Proof-of-Concept Programme for Digital Healthcare in Chaoyang District, Beijing. This initiative aims to create China's first comprehensive liver disease management platform utilizing AI technologies, aligning with the World Health Organization's goal to eliminate viral hepatitis by 2030. The project is expected to generate stable revenue for HealthyWay Inc. and serve as a model for managing other chronic diseases, reinforcing the company's position in the digital health and wellness industry in China.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthyWay Inc. published the original content used to generate this news brief on June 16, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.